{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:35:28Z","timestamp":1783532128636,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,9,12]],"date-time":"2014-09-12T00:00:00Z","timestamp":1410480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2014,9,12]],"date-time":"2014-09-12T00:00:00Z","timestamp":1410480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2014.65","type":"journal-article","created":{"date-parts":[[2014,9,12]],"date-time":"2014-09-12T15:53:34Z","timestamp":1410537214000},"page":"e245-e245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma"],"prefix":"10.1038","volume":"4","author":[{"given":"T","family":"Mino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Takihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,12]]},"reference":[{"key":"BFbcj201465_CR1","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1002\/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3","volume":"52","author":"P Isaacson","year":"1983","unstructured":"Isaacson P, Wright DH . Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983; 52: 1410\u20131416.","journal-title":"Cancer"},{"key":"BFbcj201465_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","volume":"114","author":"A Stefanovic","year":"2009","unstructured":"Stefanovic A, Lossos IS . Extranodal marginal zone lymphoma of the ocular adnexa. Blood 2009; 114: 501\u2013510.","journal-title":"Blood"},{"key":"BFbcj201465_CR3","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/0046-8177(90)90181-4","volume":"21","author":"DM Knowles","year":"1990","unstructured":"Knowles DM, Jakobiec FA, McNally L, Burke JS . Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol 1990; 21: 959\u2013973.","journal-title":"Hum Pathol"},{"key":"BFbcj201465_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/PAP.0b013e3181e4abdb","volume":"17","author":"PA McKelvie","year":"2010","unstructured":"McKelvie PA . Ocular adnexal lymphomas: a review. Adv Anat Pathol 2010; 17: 251\u2013261.","journal-title":"Adv Anat Pathol"},{"key":"BFbcj201465_CR5","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/S0161-6420(95)30764-6","volume":"102","author":"WL White","year":"1995","unstructured":"White WL, Ferry JA, Harris NL, Grove AS Jr . Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type. Ophthalmology 1995; 102: 1994\u20132006.","journal-title":"Ophthalmology"},{"key":"BFbcj201465_CR6","doi-asserted-by":"publisher","first-page":"e659","DOI":"10.1016\/j.ijrobp.2011.03.050","volume":"81","author":"JS Goda","year":"2011","unstructured":"Goda JS, Le LW, Lapperriere NJ, Millar BA, Payne D, Gospodarowicz MK et alLocalized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity. Int J Radiat Oncol Biol Phys 2011; 81: e659\u2013e666.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFbcj201465_CR7","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/cncr.11539","volume":"98","author":"T Uno","year":"2003","unstructured":"Uno T, Isobe K, Shikama N, Nishikawa A, Oguchi M, Ueno N et alRadiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients. Cancer 2003; 98: 865\u2013871.","journal-title":"Cancer"},{"key":"BFbcj201465_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00277-004-0914-3","volume":"84","author":"JL Lee","year":"2005","unstructured":"Lee JL, Kim MK, Lee KH, Hyun MS, Chung HS, Kim DS et alExtranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa. Ann Hematol 2005; 84: 13\u201318.","journal-title":"Ann Hematol"},{"key":"BFbcj201465_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.radonc.2005.11.005","volume":"78","author":"Y Ejima","year":"2006","unstructured":"Ejima Y, Sasaki R, Okamoto Y, Maruta T, Azumi A, Hayashi Y et alOcular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy. Radiother Oncol 2006; 78: 6\u20139.","journal-title":"Radiother Oncol"},{"key":"BFbcj201465_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0167-8140(00)00328-5","volume":"59","author":"SL Stafford","year":"2001","unstructured":"Stafford SL, Kozelsky TF, Garrity JA, Kurtin PJ, Leavitt JA, Martenson JA et alOrbital lymphoma: radiotherapy outcome and complications. Radiother Oncol 2001; 59: 139\u2013144.","journal-title":"Radiother Oncol"},{"key":"BFbcj201465_CR11","first-page":"1578","volume":"90","author":"AJ Ferreri","year":"2005","unstructured":"Ferreri AJ, Ponzoni M, Martinelli G, Muti G, Guidoboni M, Dolcetti R et alRituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa. Haematologica 2005; 90: 1578\u20131579.","journal-title":"Haematologica"},{"key":"BFbcj201465_CR12","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","volume":"102","author":"A Conconi","year":"2003","unstructured":"Conconi A, Martinelli G, Thieblemont C, Ferreri AJ, Devizzi L, Peccatori F et alClinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003; 102: 2741\u20132745.","journal-title":"Blood"},{"key":"BFbcj201465_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S1470-2045(14)70027-0","volume":"15","author":"KM Ardeshna","year":"2014","unstructured":"Ardeshna KM, Qian W, Smith P, Braganca N, Lowry L, Patrick P et alRituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial. Lancet Oncol 2014; 15: 424\u2013435.","journal-title":"Lancet Oncol"},{"key":"BFbcj201465_CR14","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.ijrobp.2011.04.052","volume":"82","author":"N Hashimoto","year":"2012","unstructured":"Hashimoto N, Sasaki R, Nishimura H, Yoshida K, Miyawaki D, Nakayama M et alLong-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 2012; 82: 1509\u20131514.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFbcj201465_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ijrobp.2005.11.035","volume":"65","author":"CO Suh","year":"2006","unstructured":"Suh CO, Shim SJ, Lee SW, Yang WI, Lee SY, Hahn JS . Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior. Int J Radiat Oncol Biol Phys 2006; 65: 228\u2013233.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bcj201465.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201465","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201465.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T22:56:59Z","timestamp":1672959419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj201465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,12]]},"references-count":15,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9]]}},"alternative-id":["BFbcj201465"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2014.65","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,12]]},"assertion":[{"value":"12 September 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}